Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 10Colorectal Neoplasms 8Postoperative Complications 2Anastomotic Leak 2Transfusion Reaction 1Sarcopenia 1Peritoneal Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Metabolomics 1Intestinal Perforation 1Ileus 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis 1Cholecystolithiasis 1Carcinoma, Hepatocellular 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 11Mitomycin 11Leucovorin 7Hyperthermic Intraperitoneal Chemotherapy 7Irinotecan 6Fluorouracil 6Cisplatin 4Capecitabine 4Surveys and Questionnaires 3Doxorubicin 3Cytoreduction Surgical Procedures 3dehydroftorafur 2Trastuzumab 2Thalidomide 2Mitozytrex 2Melphalan 2Interleukin-12 Subunit p35 2Floxuridine 2Drug Therapy 2Cetuximab 2Biopsy 2tipifarnib 1surufatinib 1sodium thiosulfate 1sintilimab 1nintedanib 1nilotinib 1motexafin lutetium 1irinotecan sucrosofate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × Colectomy × Clear all
NCT05452382 2022-07-11

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma

Mansoura University

Completed
2,607 enrolled
Gastrointestinal

Appendiceal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡